We distill cutting-edge medical technologies to their essence, then re-invent them as affordable, reliable, easy-to-use tools that work in places where resources are limited, power is scarce, or trained health care workers are few and far between.
Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC (brand name Sayana® Press), an all-in-one contraceptive that puts women in charge of their reproductive health.
The world has changed in remarkable—even unprecedented—ways since PATH got its start. Now we're accelerating our efforts to create greater health, equity, and opportunity everywhere.
A new quest to find impactful healthcare innovations in India
At PATH, we connect local innovators and decision-makers with our global network of partners to develop responsive, human-centered solutions to health challenges.
Research in Uganda and elsewhere has shown that women are able to self-administer DMPA-SC safely and effectively, that they like doing so, and that self-injection helps support women to continue using injectable contraception.
Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.